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Abstract 
De Sanctis-Cacchione syndrome is an extremely rare 
disorder characterized by the skin and eye symptoms 
of xeroderma pigmentosum that occur along with 
neurological abnormalities, microcephaly, 
progressive mental retardation, dwarfism, 
hypogonadism, deafness, ataxia and quadriparesis. 
This syndrome is the most severe form of XP. It has 
also been associated with mutations in the ERCC6, 
XPA, ERCC2 (XPD), and XPC genes, which play 
roles in the transcription coupled nucleotide excision 
repair system. 
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Identity 
This syndrome is the most severe form of xeroderma 
pigmentosum (XP) (Atlas ID #10004). 
Inheritance 
Autosomal recessive 
Clinics 
Phenotype and clinics 
De Sanctis-Cacchione syndrome is characterized by 
the skin and eye symptoms of XP along with 
neurological symptoms and growth delays. The 
severity of the clinical presentations varies 
depending on the nature of the mutation and amount 
of sun exposure. The earliest skin conditions include 
persistent erythema, increased freckling and 
blistering that occur after exposure to sunlight. In 
most cases, onset of these symptoms is often during 
infancy, although symptoms may not be apparent 
until later in childhood in rare cases. Additional skin 
symptoms include hyperpigmentation, 
hypopigmentation, or complete depigmentation.  
Some patients may develop premalignant lesions 
such as actinic keratoses. These patients may 
experience an early onset of skin cancer.  
For example, skin cancers such as malignant 
melanoma, basal cell carcinoma, and squamous cell 
carcinoma often occur, and the most commonly 
affected areas are the head, neck, and face.  
In De Sanctis-Cacchione syndrome, some of the eye 
symptoms associated with XP may be present, such 
as photophobia, keratitis, or conjunctivitis. The 
severity of symptoms related to the skin and eyes 
may depend on the amount of exposure to ultraviolet 
light.  
Most patients with De Sanctis-Cacchione syndrome 
usually have one or more neurological abnormalities 
with the most frequent being mental retardation.  
Other abnormalities may include microcephaly, 
sensorineural deafness, dysarthria, areflexia, 
hyporeflexia, or spasticity.  
Affected individuals may also demonstrate ataxia or 
choreoathetosis.  
Shortening of the Achilles tendon can lead to 
quadriparesis.  
Individuals with De Sanctis-Cacchione syndrome 
will also exhibit unusually slow development, 
profound growth delays resulting in dwarfism and 
hypogonadism. 
Differential Diagnosis 
Xeroderma pigmentosum:  Typically, XP patients 
have a similar skin presentation as noted above. 
However, De Sanctis-Cacchione syndrome is the 
rarest manifestations of XP with the most severe 
DNA repair impairment. XP can also present with 
some neurologic manifestations; however, short 
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stature and delayed gonadal maturation are more 
typical of De Sanctis-Cacchione syndrome. The 
presence of progressive neurologic involvement and 
age at symptom onset correlate with the degree of 
DNA repair impairment present (Rahbar 2015).  
Cockayne syndrome:  Patients have a typical face 
phenotype (microcephaly, wizened face, deep-set 
eyes, mandible prognathism, hypoplastic teeth, and 
malformed ears) and develop dwarfism, 
hypogonadism, and neurological abnormalities 
similar to De Sanctis-Cacchione syndrome that 
include progressive impairment of vision, hearing 
and speech, behavioral changes, intellectual 
disability, and ataxia, leading to severe disability 
(Uribe-Bojanini 2017). However, cases of De 
Sanctis-Cacchione syndrome can be distinguished 
from Cockayne syndrome since patients with 
Cockayne syndrome do not show XP-type skin 
findings or have increased risk of skin cancer. 
Conversely, patients with Cockayne syndrome tend 
to have normal or increased deep tendon reflexes or 
signs of primary demyelination (Moriwaki 1996).  
Although the diagnosis of De Sanctis-Cacchione 
syndrome can be suspected by the patient's clinical 
presentation, molecular genetic testing is 
recommended for confirmation of the patient's 
mutation and complementation group 
characterization. The nucleotide excision repair 
(NER) system includes seven complementation 
groups XP-A to XP-G in addition to the XP variant 
group. NER is responsible for repairing UV-induced 
photoproducts inside DNA. If a mutation is present 
in any of the components of the pathway, then the 
entire pathway fails to function normally. Thus, 
identification of the patient's mutation and 
complementation group characterization plays an 
important role in genetic counseling, antenatal 
diagnosis, discussion of etiology, and the probability 
of occurrence in future generations (Uribe-Bojanini 
2017). 
Neoplastic risk 
Patients have a 10,000-fold increase in the risk of 
developing skin basal cell carcinoma and squamous 
cell carcinoma and a 2,000-fold increased risk of 
melanoma (Uribe-Bojanini 2017). 
Treatment 
Total protection of the skin from sunlight is 
important to prevent the development of skin lesions. 
Protective methods include use of topical 
sunscreens, sunglasses, and photoprotective layers 
of clothing. For the treatment of established skin 
lesions, chemotherapeutic agents, such as 5-
fluorouracil, immunomodulators and retinoids, can 
be used depending on the location, severity and 
extension of the lesion (Caldas 2013).  
Vitamin D supplementation may be necessary due to 
deficiency from rigorous sun protection. 
Psychological advisory and support groups are very 
important for patients and their families. The 
management of patients with neurological 
abnormalities includes the use of hearing aid 
devices, along with physical, occupational, and 
speech therapy. Genetic counseling should be 
offered for families at risk. (Uribe-Bojanini 2017). 
Prognosis 
The prognosis of the disease is poor overall. 
Genes involved and 
proteins 
The nucleotide excision repair (NER) system 
includes seven complementation groups XP-A to 
XP-G in addition to the XP variant group. NER is 
responsible for repairing UV-induced photoproducts 
inside DNA. If a mutation is present in any of the 
components of the pathway, then the entire pathway 
fails to function normally. Patients with De Sanctis-
Cacchione syndrome have been found to harbor 
mutations in ERCC6 (CSB), XPA, ERCC2 (XPD), 
and XPC genes. 
ERCC6 (excision repair cross-
complementing rodent repair 
deficiency, group 6) 
Alias 
CSB (Cockayne syndrome B), CKN2, ARMD5, 
RAD26 
Location 10q11.23 
DNA/RNA 
Description 
90 kbp; at least 21 exons 
Protein 
The ERCC6 gene encodes the CSB protein. 
Description 
1493-amino acid protein has an N-terminal domain, 
followed by an acidic stretch, a glycine-rich region, 
a central helicase domain, and a nuclear localization 
signal (Troelstra et al. 1992). 
Expression 
Ubiquitous. 
Localisation 
Nuclear. 
Function 
Encodes a DNA-binding protein (CSB) that plays a 
role in transcription-coupled excision repair. The 
encoded protein has ATP-stimulated ATPase 
activity, interacts with several transcription and 
excision repair proteins, and may promote complex 
formation at DNA repair sites (Troelstra et al. 1992). 
CSB is essential for the NER system, which removes 
RNA polymerase blocking lesions. The CSB protein 
plays an important role in general nuclear 
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transcription and stimulates RNA polymerase II 
progression beyond pause sites (Shehata 2014). 
Mutations 
Germinal 
Biallelic mutations have been found in the ERCC6 
genomic DNA (C2282T) of three patients with De 
Sanctis-Cacchione syndrome. 
XPA (Xeroderma pigmentosum, 
complementation group A) 
Alias 
XP-A, xeroderma pigmentosum, complementation 
group A, XP1, XPA_HUMAN, XPAC 
Location 9q22.33 
DNA/RNA 
Description 
22448 bp; 6 exons. 
Protein 
Description 
273 amino acids, 31.4 kDa. DNA excision repair 
protein. The functional domain for damaged DNA 
recognition contains a zinc-finger motif with 4 
cysteine residues: Cys-X2-Cys-X17-Cys-X2-Cys 
motif and a glutamic acid cluster encoded by Exon 
2. The nuclear localization signal is located in Exon
1. 
Expression 
Ubiquitous. 
Localisation 
Nuclear. 
Function 
Initiates DNA repair by binding to damaged sites 
with various affinities, depending on the chemical 
structure of the lesion. Two proteins have been 
identified and implicated in one of the first steps of 
NER system to recognize lesions in DNA: the XPA 
gene product and the XPC gene product. In vitro the 
XPA protein binds preferentially to damaged DNA 
compared to non-damaged DNA. The XPA protein 
binds to replication protein A (RPA) which enhances 
the affinity of XPA for damaged DNA and is 
essential for NER. The XPA protein has been shown 
to bind to ERCC1 and TFIIH. It is possible that the 
complex XPA/RPA may inform the repair 
machinery which strand contains the damage and be 
eliminated. 
Mutations 
Germinal 
13 nucleotide substitutions and 5 small 
insertion/deletion. 
ERCC2 (Excision repair cross-
complementing rodent repair 
deficiency, complementation group 
2) 
Alias 
XPD, XP-D, xeroderma pigmentosum 
complementary group D 
Location 19q13.32 
DNA/RNA 
Description 
54336 bp; 23 exons 
Transcription 
2400b mRNA 
Protein 
Description 
760 amino acids. 
Expression 
Ubiquitous. 
Localisation 
Nuclear. 
Function 
5'-3' ATP-dependent helicase activity involved in 
DNA NER pathway and as a subunit of the basal 
transcription factor TFIIH.  
The ERCC2 (XPD) as the ERCC3 (XPB) protein are 
also found in the transcription factor TFIIH, a large 
complex involved in the initiation of transcription. 
TFIIH fulfills a dual role in transcription initiation 
and NER and the role of TFIIH in NER might closely 
mimic its role in the transcription initiation process. 
In transcription initiation, TFIIH is thought to be 
involved in unwinding of the promoter site and to 
allow promoter clearance. In the NER process, 
TFIIH causes unwinding of the damaged region that 
has been localized by XPC- RAD23B (HR23B) and 
XPA-RPA, enabling the accumulation of NER 
proteins around the damaged site. 
Mutations 
Germinal 
17 mutated sites. 
XPC (xeroderma pigmentosum, 
complementation group C) 
Alias 
XP-C, XPCC, RAD4, xeroderma pigmentosum, 
complementation group C 
Location 3p25.1 
DNA/RNA 
Description 
17703 bp; 16 exons. 
Transcription 
3558b mRNA. 
Protein 
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Description 
939 amino acids. 
Expression 
Ubiquitous. 
Localisation 
Nuclear. 
Function 
Involved in the early recognition of DNA damage 
present in chromatin. Two proteins have been 
identified and implicated in (one of) the first steps of 
NER system to recognize lesions in DNA: the XPA 
gene product and the XPC gene product in complex 
with HR23B. The XPC-HR23B complex has been 
implicated in DNA damage recognition, especially 
the cyclobutane pyrimidine dimers induced by UV-
light. XPC cells have low NER capacity, but the 
residual repair has been shown to occur specifically 
in transcribed genes. It is very likely that the XPC-
HR23B complex is the principal damage recognition 
complex. Binding of XPC-HR23B to a DNA lesion 
causes local unwinding, so that the XPA protein can 
bind and the whole repair machinery can be loaded 
onto the damaged site. The XPC-HR23B complex is 
only required for global genome repair. In case of 
transcription coupled repair when an RNA 
polymerase is stalled at a lesion, the DNA is 
unwound by the transcription complex and XPA can 
bind independently of the XPC-HR23B complex. 
Mutations 
Germinal 
A novel germline mutation in the XPC gene 
(c.547A>T) was identified in one case causing De 
Sanctis-Cacchione syndrome. This variant is 
predicted to result in premature protein termination  
(p.Lys183*) (Uribe-Bojanini 2017). 
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